Yamauchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H
Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
FEBS Lett. 1990 Jul 2;267(1):16-8. doi: 10.1016/0014-5793(90)80276-o.
We have investigated the effect of glucose on the release of endothelin-1-like immunoreactivity (ET-1-LI) from cultured bovine aortic endothelial cells. Elevation of glucose concentrations in cultured media from 5.5 to 11.1 or 22.2 mM significantly stimulated ET-1-LI release from cultured endothelial cells. An aldose reductase inhibitor did not affect the high glucose-induced ET-1-LI release. These findings suggest the possibility that hyperglycemia in diabetic patients enhances ET-1-LI release at the local site of vascular endothelium, which might be involved in the developments of vascular complications and atherosclerosis.
我们研究了葡萄糖对培养的牛主动脉内皮细胞释放内皮素 -1 样免疫反应性物质(ET -1 -LI)的影响。将培养基中的葡萄糖浓度从 5.5 mM 提高到 11.1 mM 或 22.2 mM 可显著刺激培养的内皮细胞释放 ET -1 -LI。醛糖还原酶抑制剂不影响高糖诱导的 ET -1 -LI 释放。这些发现提示糖尿病患者的高血糖可能会增强血管内皮局部部位的 ET -1 -LI 释放,这可能与血管并发症和动脉粥样硬化的发生有关。